Radio and PodcastLive Radio & PodcastsScience & Medicine
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk agai...
About This Episode
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Listen to an audio podc...
Podcast
This episode belongs to FDA Drug Safety Podcasts.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Feb 9, 2022, 3:30 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Safety Podcasts.
Questions About This Episode
What is FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) about?
Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses.
Where can I listen to FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)?
You can listen to FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) from?
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) is an episode from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.
How long is this episode?
This episode is 3:30 long.
When was this episode published?
This episode was published on Feb 9, 2022.
Can I save FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Safety Podcasts?
Yes. This page shows related episodes from FDA Drug Safety Podcasts when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)?
You can listen to FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) is from FDA Drug Safety Podcasts by U.S. Food and Drug Administration, Center for Drug Evaluation and Research.
What are the episode details?
Published Feb 9, 2022 and 3:30 long